Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Chemed Co. stock logo
CHE
Chemed
$565.59
+0.9%
$623.29
$492.84
$654.62
$8.55B0.4279,299 shs21,360 shs
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$6.31
+1.8%
$6.44
$4.74
$9.59
$2.41B1.341.29 million shs231,594 shs
Oak Street Health, Inc. stock logo
OSH
Oak Street Health
$39.00
$37.57
$13.29
$39.00
$9.52B2.235.76 million shsN/A
Qiagen stock logo
QGEN
Qiagen
$42.24
+1.4%
$42.58
$34.74
$47.70
$9.64B0.411.19 million shs949,036 shs
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Chemed Co. stock logo
CHE
Chemed
0.00%-6.66%-12.70%-6.12%+1.66%
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
0.00%+8.58%+0.49%-5.92%-23.93%
Oak Street Health, Inc. stock logo
OSH
Oak Street Health
0.00%0.00%0.00%0.00%+0.08%
Qiagen stock logo
QGEN
Qiagen
0.00%+4.13%-3.12%-7.74%-9.44%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Chemed Co. stock logo
CHE
Chemed
4.7136 of 5 stars
2.53.03.34.91.12.52.5
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
2.0674 of 5 stars
3.12.00.00.02.82.50.6
Oak Street Health, Inc. stock logo
OSH
Oak Street Health
N/AN/AN/AN/AN/AN/AN/AN/A
Qiagen stock logo
QGEN
Qiagen
4.6006 of 5 stars
2.35.00.04.53.11.72.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Chemed Co. stock logo
CHE
Chemed
3.00
Buy$681.0020.41% Upside
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
2.17
Hold$8.8339.99% Upside
Oak Street Health, Inc. stock logo
OSH
Oak Street Health
N/AN/AN/AN/A
Qiagen stock logo
QGEN
Qiagen
2.63
Moderate Buy$51.6922.37% Upside

Current Analyst Ratings

Latest OSH, LFST, QGEN, and CHE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/22/2024
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$10.00 ➝ $10.00
3/6/2024
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$8.00 ➝ $9.00
3/4/2024
Chemed Co. stock logo
CHE
Chemed
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$604.00 ➝ $712.00
3/4/2024
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$8.00 ➝ $9.00
2/29/2024
Chemed Co. stock logo
CHE
Chemed
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$625.00 ➝ $650.00
2/29/2024
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderweight ➝ Underweight$7.00 ➝ $8.00
2/16/2024
Qiagen stock logo
QGEN
Qiagen
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$49.48 ➝ $51.00
2/8/2024
Qiagen stock logo
QGEN
Qiagen
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$50.00 ➝ $52.00
2/8/2024
Qiagen stock logo
QGEN
Qiagen
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$61.86 ➝ $60.00
(Data available from 4/29/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Chemed Co. stock logo
CHE
Chemed
$2.26B3.78$24.78 per share22.82$73.55 per share7.69
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$1.06B2.28N/AN/A$3.77 per share1.67
Oak Street Health, Inc. stock logo
OSH
Oak Street Health
$2.16B4.40N/AN/A($1.10) per share-35.45
Qiagen stock logo
QGEN
Qiagen
$1.97B4.90$3.17 per share13.34$16.69 per share2.53

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Chemed Co. stock logo
CHE
Chemed
$272.51M$18.5830.4423.552.2812.36%30.52%20.13%7/24/2024 (Estimated)
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
-$186.26M-$0.51N/AN/AN/A-17.64%-12.66%-8.65%5/9/2024 (Confirmed)
Oak Street Health, Inc. stock logo
OSH
Oak Street Health
-$509.20M-$2.21N/AN/AN/A-23.57%N/A-25.08%N/A
Qiagen stock logo
QGEN
Qiagen
$341.30M$1.5127.9218.693.5117.37%12.99%7.74%4/29/2024 (Confirmed)

Latest OSH, LFST, QGEN, and CHE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
-$0.09N/A+$0.09N/AN/AN/A  
4/29/2024N/A
Qiagen stock logo
QGEN
Qiagen
$0.44N/A-$0.44N/AN/AN/A  
4/24/2024Q1 2024
Chemed Co. stock logo
CHE
Chemed
$5.09$4.68-$0.41$5.12$587.18 million$589.23 million    
2/28/2024Q4 2023
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
-$0.09-$0.12-$0.03-$0.12$263.14 million$280.60 million
2/27/2024Q4 2023
Chemed Co. stock logo
CHE
Chemed
$6.25$6.60+$0.35$7.30$586.64 million$585.90 million    
2/6/2024Q4 23
Qiagen stock logo
QGEN
Qiagen
$0.55$0.55N/A$0.68$500.77 million$509.00 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Chemed Co. stock logo
CHE
Chemed
$1.600.28%+5.73%8.61%15 Years
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
N/AN/AN/AN/AN/A
Oak Street Health, Inc. stock logo
OSH
Oak Street Health
N/AN/AN/AN/AN/A
Qiagen stock logo
QGEN
Qiagen
N/AN/AN/AN/AN/A

Latest OSH, LFST, QGEN, and CHE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/16/2024
Chemed Co. stock logo
CHE
Chemed
quarterly$0.400.27%2/23/20242/26/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Chemed Co. stock logo
CHE
Chemed
N/A
1.91
1.88
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
0.20
1.11
1.11
Oak Street Health, Inc. stock logo
OSH
Oak Street Health
N/A
1.41
1.41
Qiagen stock logo
QGEN
Qiagen
0.24
1.99
1.62

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Chemed Co. stock logo
CHE
Chemed
95.85%
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
85.50%
Oak Street Health, Inc. stock logo
OSH
Oak Street Health
92.04%
Qiagen stock logo
QGEN
Qiagen
70.00%

Insider Ownership

CompanyInsider Ownership
Chemed Co. stock logo
CHE
Chemed
3.32%
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
8.50%
Oak Street Health, Inc. stock logo
OSH
Oak Street Health
11.55%
Qiagen stock logo
QGEN
Qiagen
9.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Chemed Co. stock logo
CHE
Chemed
15,08715.12 million14.62 millionOptionable
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
9,325382.24 million349.75 millionOptionable
Oak Street Health, Inc. stock logo
OSH
Oak Street Health
6,000244.00 million215.82 millionNot Optionable
Qiagen stock logo
QGEN
Qiagen
5,967228.20 million207.67 millionOptionable

OSH, LFST, QGEN, and CHE Headlines

SourceHeadline
Qiagen Q1 2024 Earnings PreviewQiagen Q1 2024 Earnings Preview
msn.com - April 28 at 8:17 PM
Qiagen (NYSE:QGEN) Short Interest UpdateQiagen (NYSE:QGEN) Short Interest Update
americanbankingnews.com - April 28 at 3:14 AM
7 Best Sites Like Ancestry.com to Research Your Family History7 Best Sites Like Ancestry.com to Research Your Family History
finance.yahoo.com - April 26 at 2:03 AM
QIAGEN N.V.: QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistanceQIAGEN N.V.: QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance
finanznachrichten.de - April 25 at 5:29 AM
QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistanceQIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance
globenewswire.com - April 24 at 4:05 PM
Unveiling Qiagen (QGEN) Q1 Outlook: Wall Street Estimates for Key MetricsUnveiling Qiagen (QGEN) Q1 Outlook: Wall Street Estimates for Key Metrics
zacks.com - April 24 at 10:21 AM
Qiagen (QGEN) Set to Announce Quarterly Earnings on MondayQiagen (QGEN) Set to Announce Quarterly Earnings on Monday
americanbankingnews.com - April 22 at 3:12 AM
Bank of America Securities Reaffirms Their Buy Rating on Qiagen (QGEN)Bank of America Securities Reaffirms Their Buy Rating on Qiagen (QGEN)
markets.businessinsider.com - April 17 at 3:58 PM
QIAGEN N.V. to release results for Q1 2024 and hold webcastQIAGEN N.V. to release results for Q1 2024 and hold webcast
globenewswire.com - April 9 at 9:48 AM
Qiagen (NYSE:QGEN) Given Average Recommendation of "Moderate Buy" by AnalystsQiagen (NYSE:QGEN) Given Average Recommendation of "Moderate Buy" by Analysts
marketbeat.com - April 9 at 4:26 AM
QIAGEN (QGEN) Boosts Cancer Research Suite With New LaunchesQIAGEN (QGEN) Boosts Cancer Research Suite With New Launches
zacks.com - April 4 at 2:26 PM
QIAGEN N.V.: QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024QIAGEN N.V.: QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024
finanznachrichten.de - April 4 at 9:11 AM
QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024
globenewswire.com - April 3 at 4:05 PM
Qiagen (NYSE:QGEN) Shares Gap Down to $42.21Qiagen (NYSE:QGEN) Shares Gap Down to $42.21
marketbeat.com - April 3 at 1:36 PM
QGEN Makes Notable Cross Below Critical Moving AverageQGEN Makes Notable Cross Below Critical Moving Average
nasdaq.com - March 27 at 8:21 PM
MyBio Are the New Exclusive Partner for QIAGEN in Ireland & Northern IrelandMyBio Are the New Exclusive Partner for QIAGEN in Ireland & Northern Ireland
businesswire.com - March 27 at 12:31 PM
QIAGEN (QGEN) Unveils QIAstat-Dx Analyzer With Remote AccessQIAGEN (QGEN) Unveils QIAstat-Dx Analyzer With Remote Access
zacks.com - March 26 at 11:11 AM
QIAGEN N.V.: QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare systemQIAGEN N.V.: QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system
finanznachrichten.de - March 26 at 6:00 AM
QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare systemQIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system
globenewswire.com - March 25 at 4:05 PM
QIAGEN (QGEN) Partners With IPPA to Raise TB Screening AwarenessQIAGEN (QGEN) Partners With IPPA to Raise TB Screening Awareness
zacks.com - March 25 at 10:10 AM
Has Qiagen N.V. (NYSE:QGEN) Stocks Recent Performance Got Anything to Do With Its Financial Health?Has Qiagen N.V. (NYSE:QGEN) Stock's Recent Performance Got Anything to Do With Its Financial Health?
finance.yahoo.com - March 21 at 8:14 AM
Qiagen teams with International Panel Physicians Association for tuberculosis screening awarenessQiagen teams with International Panel Physicians Association for tuberculosis screening awareness
fiercepharma.com - March 20 at 3:42 PM
QIAGEN N.V.: QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirementsQIAGEN N.V.: QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirements
finanznachrichten.de - March 19 at 8:33 AM
QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirementsQIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirements
globenewswire.com - March 18 at 4:05 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Chemed logo

Chemed

NYSE:CHE
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
LifeStance Health Group logo

LifeStance Health Group

NASDAQ:LFST
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.
Oak Street Health logo

Oak Street Health

NYSE:OSH
Oak Street Health, Inc., together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas. The company was founded in 2012 and is headquartered in Chicago, Illinois.
Qiagen logo

Qiagen

NYSE:QGEN
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. Further, the company provides predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.